title: 2D_RG_PLATE1_REPLICATE2_H17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.86 nM of cyclophosphamide

value: cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_H19

status: Public on Mar 06 2020

type: SRA

city: Durham

first: Scott

last: Auerbach

state: North Carolina

address: 111 TW Alexander Drive

country: USA

institute: Division of the National Toxicology Program at NIEHS

library_source: transcriptomic

data_processing:
TempO-Seq analysis was performed as described previously, at a targeted sequencing depth of 500 mapped read counts per transcript (Yeakley, et al., 2017).
genome build: A pseudo human transcriptome. Sequences that were included in the pseudo human transcriptome can be found here:  https://ntp.niehs.nih.gov/ntp/research/areas/tox21/human_s1500_manifest_09182018.xlsx
Supplementary_files_format_and_content: read counts per transcript

molecule: total RNA

organism: Homo sapiens

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of cyclophosphamide

growth_protocol: Cryopreserved HepaRG cells (Lonza, Catalog:NSHPRG) were thawed, and approximately 20 000 cells per well were seeded onto collagen(I)-coated 384-well plates (Corning, Catalog: 356667) 10 days prior to compound exposures for recovery/differentiation with differentiated cultures (2D-DIFF). For proliferated/non-differentiated cultures (PROLIF), 2000 cells per well were seeded 3 days prior to chemical exposure. Cells were plated using Williams E medium (ThermoFisher, Catalog: A1217601) supplemented with plating additive (Lonza, Catalog: MHTAP), and 24h later exchanged with William’s E medium supplemented with maintenance additive (Lonza, Catalog: MHPIT) for the duration of cultures.

extract_protocol: At the end of the 96-hour compound exposure period, exposure media was removed, and cells were washed once with 50 μL Phosphate-buffered saline (ThermoFisher) followed by addition of 20 μL of 1X TempO-Seq lysis buffer (Biospyder) to culture plates. Plates were then incubated for 15 minutes at room temperature and frozen at -80° C. TempO-Seq analysis was performed as described previously, at a targeted sequencing depth of 500 mapped read counts per transcript (Yeakley, et al., 2017).

treatment_protocol: Compounds were procured from MRI Global (Kansas City, Missouri). Chemicals were blinded to the laboratory personnel involved in compound exposures. Briefly, 500X concentrations of each compound were prepared in DMSO, with the exception of phenobarbital and acetaminophen, which were prepared in exposure medium due to aqueous solubility incompatible with dissolution in DMSO. Stock concentrations (500X) were serial diluted in 96-well plates for a total of 10 concentrations (half-log spacing). From these stocks, 2 ml of each compound was stamped in a separate 96-well plate containing maintenance medium (Lonza, Catalog: MHPIT) using Vialflo semi-automated pipettor (Integra Biosciences, Catalog: 6031). Compound mixtures were subsequently mixed thoroughly, and 50 ml was transferred to the culture plates containing cells. Media from each exposed culture well were exchanged after the initial 48h of treatment, spent culture media were removed for lactate dehydrogenase (LDH) assays, and fresh exposure medium was added to the plates, as described above. The total chemical exposure period was 96 h prior to cell lysis for Tempo-Seq analysis. Three independent technical replicates per treatment group, and 3 independent experimental runs were performed in this study.

tag: cell type

value: HepaRG cells

tag: sample preparation

value: unpurified cell lysates

tag: treatment time

value: 96 hours

tag: dose

value: 30 nM

tag: chemical


title: 2D_RG_PLATE1_REPLICATE2_H21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of cyclophosphamide


title: 2D_PROL_PLATE3_REPLICATE2_P17

source_name: RNA-Seq of undifferentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE2_H16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.05 nM of rosiglitazone

value: rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_H15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.98 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_I04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300011.51 nM of aspirin

value: aspirin


title: 2D_RG_PLATE1_REPLICATE2_H14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_H11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.83 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_H12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.50 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_I12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.12 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE2_H13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.63 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_H10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9488.41 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_H09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.30 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_H08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30004.98 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_H04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300049.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_H07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29998.31 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_H05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94862.97 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_H03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299983.06 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_H02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE2_G24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO

value: DMSO


title: 2D_RG_PLATE1_REPLICATE2_G23


title: 2D_RG_PLATE1_REPLICATE2_G19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_H01


title: 2D_RG_PLATE1_REPLICATE2_G17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.86 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.88 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_G16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.05 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_G15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.98 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_G13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.63 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.83 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9488.41 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_G12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.50 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_G08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30004.98 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_G09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.30 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29998.31 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_G06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94884.09 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_G02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE2_G05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94862.97 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G01


title: 2D_RG_PLATE1_REPLICATE2_G03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299983.06 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_F21


title: 2D_RG_PLATE1_REPLICATE2_F22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_F23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE2_F20


title: 2D_RG_PLATE1_REPLICATE2_F16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.05 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_F15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.98 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_F17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.86 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_F14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_H06


title: 2D_RG_PLATE1_REPLICATE2_F11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.83 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_F18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.88 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_F08


title: 2D_RG_PLATE1_REPLICATE2_F13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.63 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_G04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300049.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_F10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9488.41 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_F07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29998.31 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_F19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_F03


title: 2D_RG_PLATE1_REPLICATE2_F12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.50 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_F01

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE2_E20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.01 nM of troglitazone

value: troglitazone


title: 2D_RG_PLATE1_REPLICATE2_E18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.91 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_F09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.30 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_E21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.48 nM of KCl

value: KCl


title: 2D_RG_PLATE1_REPLICATE2_F04


title: 2D_RG_PLATE1_REPLICATE2_E12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3001.16 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_F02


title: 2D_RG_PLATE1_REPLICATE2_F05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94862.97 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE2_E24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE2_E06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94905.00 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_E19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29.99 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_E04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300115.97 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_F06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94884.09 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE2_E14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 949.05 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_E03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299919.48 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_E16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.12 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_E02


title: 2D_RG_PLATE1_REPLICATE2_E17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.84 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_E01


title: 2D_RG_PLATE1_REPLICATE2_E22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_E23


title: 2D_RG_PLATE1_REPLICATE2_D22


title: 2D_RG_PLATE1_REPLICATE2_E15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.92 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_E11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.19 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_F24


title: 2D_RG_PLATE1_REPLICATE2_E13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.43 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_E10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9490.50 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_E07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29991.95 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_D20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.01 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_E05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94842.87 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_D16


title: 2D_RG_PLATE1_REPLICATE2_D15


title: 2D_RG_PLATE1_REPLICATE2_D14


title: 2D_RG_PLATE1_REPLICATE2_D13


title: 2D_RG_PLATE1_REPLICATE2_D12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3001.16 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_E09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9484.29 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_D24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE2_D05


title: 2D_RG_PLATE1_REPLICATE2_D07


title: 2D_RG_PLATE1_REPLICATE2_D06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94905.00 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_D03


title: 2D_RG_PLATE1_REPLICATE2_D23


title: 2D_RG_PLATE1_REPLICATE2_D02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE2_D21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.48 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_E08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30011.60 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_D18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.91 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_D19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29.99 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_C22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_D08


title: 2D_RG_PLATE1_REPLICATE2_D11


title: 2D_RG_PLATE1_REPLICATE2_C21


title: 2D_RG_PLATE1_REPLICATE2_D04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300115.97 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_C18


title: 2D_RG_PLATE1_REPLICATE2_C17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.84 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_D09


title: 2D_RG_PLATE1_REPLICATE2_C15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.92 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_D01


title: 2D_RG_PLATE1_REPLICATE2_C14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 949.05 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_C20


title: 2D_RG_PLATE1_REPLICATE2_D17


title: 2D_RG_PLATE1_REPLICATE2_C23


title: 2D_RG_PLATE1_REPLICATE2_C24


title: 2D_RG_PLATE1_REPLICATE2_C16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.12 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_D10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9490.50 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_C19


title: 2D_RG_PLATE1_REPLICATE2_C13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.43 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_C11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.19 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_C08


title: 2D_RG_PLATE1_REPLICATE2_C10


title: 2D_RG_PLATE1_REPLICATE2_C06


title: 2D_RG_PLATE1_REPLICATE2_C07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29991.95 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_C09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9484.29 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_C12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3001.16 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE2_C04


title: 2D_RG_PLATE1_REPLICATE2_C03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299919.48 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_C05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94842.87 nM of KCl


title: 2D_RG_PLATE1_REPLICATE2_C02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE2_B22


title: 2D_RG_PLATE1_REPLICATE2_B21


title: 2D_RG_PLATE1_REPLICATE2_B19


title: 2D_RG_PLATE1_REPLICATE2_B16


title: 2D_RG_PLATE1_REPLICATE2_B17


title: 2D_RG_PLATE1_REPLICATE2_B11


title: 2D_RG_PLATE1_REPLICATE2_B07


title: 2D_RG_PLATE1_REPLICATE2_B09


title: 2D_RG_PLATE1_REPLICATE2_B12


title: 2D_RG_PLATE1_REPLICATE2_B13


title: 2D_RG_PLATE1_REPLICATE2_B20


title: 2D_RG_PLATE1_REPLICATE2_A21


title: 2D_RG_PLATE1_REPLICATE2_B03


title: 2D_RG_PLATE1_REPLICATE2_B05


title: 2D_RG_PLATE1_REPLICATE2_C01


title: 2D_RG_PLATE1_REPLICATE2_B06


title: 2D_RG_PLATE1_REPLICATE2_A18


title: 2D_RG_PLATE1_REPLICATE2_B15


title: 2D_RG_PLATE1_REPLICATE2_A12


title: 2D_RG_PLATE1_REPLICATE2_A22


title: 2D_RG_PLATE1_REPLICATE2_A11


title: 2D_RG_PLATE1_REPLICATE2_A10


title: 2D_RG_PLATE1_REPLICATE2_A17


title: 2D_RG_PLATE1_REPLICATE2_B04


title: 2D_RG_PLATE1_REPLICATE2_A19


title: 2D_RG_PLATE1_REPLICATE2_A09


title: 2D_RG_PLATE1_REPLICATE2_B18


title: 2D_RG_PLATE1_REPLICATE2_A06


title: 2D_RG_PLATE1_REPLICATE2_A20


title: 2D_RG_PLATE1_REPLICATE2_A08


title: 2D_RG_PLATE1_REPLICATE2_A16


title: 2D_RG_PLATE1_REPLICATE2_A03


title: 2D_RG_PLATE1_REPLICATE1_P21


title: 2D_RG_PLATE1_REPLICATE2_A13


title: 2D_RG_PLATE1_REPLICATE2_A15


title: 2D_RG_PLATE1_REPLICATE2_A14


title: 2D_RG_PLATE1_REPLICATE2_B10


title: 2D_RG_PLATE1_REPLICATE2_B14


title: 2D_RG_PLATE1_REPLICATE2_B08


title: 2D_RG_PLATE1_REPLICATE2_A04


title: 2D_RG_PLATE1_REPLICATE2_A05


title: 2D_RG_PLATE1_REPLICATE1_P18


title: 2D_RG_PLATE1_REPLICATE1_P17


title: 2D_RG_PLATE1_REPLICATE1_P15


title: 2D_RG_PLATE1_REPLICATE1_P20


title: 2D_RG_PLATE1_REPLICATE1_P14


title: 2D_RG_PLATE1_REPLICATE1_P22


title: 2D_RG_PLATE1_REPLICATE1_P16


title: 2D_RG_PLATE1_REPLICATE1_P19


title: 2D_RG_PLATE1_REPLICATE1_P13


title: 2D_RG_PLATE1_REPLICATE1_P09


title: 2D_RG_PLATE1_REPLICATE1_P10


title: 2D_RG_PLATE1_REPLICATE1_P06


title: 2D_RG_PLATE1_REPLICATE1_P11


title: 2D_RG_PLATE1_REPLICATE1_P07


title: 2D_RG_PLATE1_REPLICATE1_P12


title: 2D_RG_PLATE1_REPLICATE1_P05


title: 2D_RG_PLATE1_REPLICATE1_O22


title: 2D_RG_PLATE1_REPLICATE1_P08


title: 2D_RG_PLATE1_REPLICATE1_P03


title: 2D_RG_PLATE1_REPLICATE1_P04


title: 2D_RG_PLATE1_REPLICATE2_A07


title: 2D_RG_PLATE1_REPLICATE1_O21


title: 2D_RG_PLATE1_REPLICATE1_O19


title: 2D_RG_PLATE1_REPLICATE1_O15


title: 2D_RG_PLATE1_REPLICATE1_O16


title: 2D_RG_PLATE1_REPLICATE1_O18


title: 2D_RG_PLATE1_REPLICATE1_O17


title: 2D_RG_PLATE1_REPLICATE1_O13


title: 2D_RG_PLATE1_REPLICATE1_O11


title: 2D_RG_PLATE1_REPLICATE1_O10


title: 2D_RG_PLATE1_REPLICATE1_O07


title: 2D_RG_PLATE1_REPLICATE1_O12


title: 2D_RG_PLATE1_REPLICATE1_O09


title: 2D_RG_PLATE1_REPLICATE1_O08


title: 2D_RG_PLATE1_REPLICATE1_O06


title: 2D_RG_PLATE1_REPLICATE1_O05


title: 2D_RG_PLATE1_REPLICATE1_O04


title: 2D_RG_PLATE1_REPLICATE1_O03


title: 2D_RG_PLATE1_REPLICATE1_N24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_N23


title: 2D_RG_PLATE1_REPLICATE1_O20


title: 2D_RG_PLATE1_REPLICATE1_N22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 0.95 nM of B[a]P

value: B[a]P


title: 2D_RG_PLATE1_REPLICATE1_N19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 15.00 nM of aflatoxin B1

value: 15 nM

value: aflatoxin


title: 2D_RG_PLATE1_REPLICATE1_N18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_N21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4.74 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_N16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_N14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.87 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_N15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149.97 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_O14


title: 2D_RG_PLATE1_REPLICATE1_N13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 474.25 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_N10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.67 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_N11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 1499.72 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_N08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.95 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_N07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 14997.23 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_N09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4742.54 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_N06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.69 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_N12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_N17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 47.43 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_N02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_N01


title: 2D_RG_PLATE1_REPLICATE1_N03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149972.33 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_M23


title: 2D_RG_PLATE1_REPLICATE1_N20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3.00 nM of B[a]P

value: 3 nM


title: 2D_RG_PLATE1_REPLICATE1_M22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 0.95 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_M21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4.74 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M20


title: 2D_RG_PLATE1_REPLICATE1_M19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 15.00 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M17


title: 2D_RG_PLATE1_REPLICATE1_M18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_M15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149.97 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.87 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_M12


title: 2D_RG_PLATE1_REPLICATE1_L24


title: 2D_RG_PLATE1_REPLICATE1_N05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 47425.41 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_L20


title: 2D_RG_PLATE1_REPLICATE1_M06


title: 2D_RG_PLATE1_REPLICATE1_M10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.67 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_M08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.95 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_M13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 474.25 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 1499.72 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_L19


title: 2D_RG_PLATE1_REPLICATE1_N04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29999.55 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_L21


title: 2D_RG_PLATE1_REPLICATE1_M07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 14997.23 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4742.54 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M05


title: 2D_RG_PLATE1_REPLICATE1_L14


title: 2D_RG_PLATE1_REPLICATE1_L13


title: 2D_RG_PLATE1_REPLICATE1_L16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_L22


title: 2D_RG_PLATE1_REPLICATE1_M03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149972.33 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M04


title: 2D_RG_PLATE1_REPLICATE1_L15


title: 2D_RG_PLATE1_REPLICATE1_M01

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_M16


title: 2D_RG_PLATE1_REPLICATE1_L11


title: 2D_RG_PLATE1_REPLICATE1_L18


title: 2D_RG_PLATE1_REPLICATE1_L12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_L17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 47.43 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_M02


title: 2D_RG_PLATE1_REPLICATE1_L08


title: 2D_RG_PLATE1_REPLICATE1_L07


title: 2D_RG_PLATE1_REPLICATE1_L03


title: 2D_RG_PLATE1_REPLICATE1_L10


title: 2D_RG_PLATE1_REPLICATE1_L04


title: 2D_RG_PLATE1_REPLICATE1_K22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_L06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.69 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE1_L02


title: 2D_RG_PLATE1_REPLICATE1_L05


title: 2D_RG_PLATE1_REPLICATE1_K21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 6.33 nM of CDCA

value: CDCA


title: 2D_RG_PLATE1_REPLICATE1_L01


title: 2D_RG_PLATE1_REPLICATE1_K24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_K17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63.26 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_L23


title: 2D_RG_PLATE1_REPLICATE1_K18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.87 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.72 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 632.57 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_K16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.01 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 20.00 nM of CDCA

value: 20 nM


title: 2D_RG_PLATE1_REPLICATE1_K08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30001.15 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9487.20 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.12 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_L09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4742.54 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE1_K09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 6325.73 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_K23


title: 2D_RG_PLATE1_REPLICATE1_K05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63257.30 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_K11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2000.37 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_K02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_K04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300011.51 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 20003.71 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_K06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94871.97 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K01


title: 2D_RG_PLATE1_REPLICATE1_J23


title: 2D_RG_PLATE1_REPLICATE1_K03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 200037.13 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_J20


title: 2D_RG_PLATE1_REPLICATE1_J21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 6.33 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.87 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_K15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 200.04 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63.26 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 632.57 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.72 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_J16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.01 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_J11


title: 2D_RG_PLATE1_REPLICATE1_J10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9487.20 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_J15


title: 2D_RG_PLATE1_REPLICATE1_J09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 6325.73 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J07


title: 2D_RG_PLATE1_REPLICATE1_J08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30001.15 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_J06


title: 2D_RG_PLATE1_REPLICATE1_J05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63257.30 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J03


title: 2D_RG_PLATE1_REPLICATE1_J04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300011.51 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_I23


title: 2D_RG_PLATE1_REPLICATE1_J02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_I24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_J19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 20.00 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_J01


title: 2D_RG_PLATE1_REPLICATE1_I22


title: 2D_RG_PLATE1_REPLICATE1_I21


title: 2D_RG_PLATE1_REPLICATE1_I20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_I15


title: 2D_RG_PLATE1_REPLICATE1_I18


title: 2D_RG_PLATE1_REPLICATE1_J12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.12 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_I19


title: 2D_RG_PLATE1_REPLICATE1_I17


title: 2D_RG_PLATE1_REPLICATE1_I13


title: 2D_RG_PLATE1_REPLICATE1_I12


title: 2D_RG_PLATE1_REPLICATE1_I14


title: 2D_RG_PLATE1_REPLICATE1_I09


title: 2D_RG_PLATE1_REPLICATE1_I10


title: 2D_RG_PLATE1_REPLICATE1_I07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 20003.71 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_I11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2000.37 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_I08


title: 2D_RG_PLATE1_REPLICATE1_I03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 200037.13 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_I04


title: 2D_RG_PLATE1_REPLICATE1_I02


title: 2D_RG_PLATE1_REPLICATE1_I01


title: 2D_RG_PLATE1_REPLICATE1_I16


title: 2D_RG_PLATE1_REPLICATE1_H24


title: 2D_RG_PLATE1_REPLICATE1_H22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.05 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H23


title: 2D_RG_PLATE1_REPLICATE1_H20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.88 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_H17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.86 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_H15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.98 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_H14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.83 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_H12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.50 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9488.41 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_I05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63257.30 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE1_H09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.30 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_H19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_H06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94884.09 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300049.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29998.31 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_H01

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_G23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_G24


title: 2D_RG_PLATE1_REPLICATE1_H08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30004.98 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_G22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_G16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.05 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_G20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_G21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_G15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.98 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_G19


title: 2D_RG_PLATE1_REPLICATE1_H13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.63 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_G17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.86 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_G13


title: 2D_RG_PLATE1_REPLICATE1_G18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.88 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_I06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94871.97 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE1_G14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_G12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.50 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94862.97 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_H02


title: 2D_RG_PLATE1_REPLICATE1_G11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.83 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_G08


title: 2D_RG_PLATE1_REPLICATE1_G10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9488.41 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_G05


title: 2D_RG_PLATE1_REPLICATE1_G09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.30 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_G06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94884.09 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_H03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299983.06 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_F22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_G02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_F23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_F24


title: 2D_RG_PLATE1_REPLICATE1_G01


title: 2D_RG_PLATE1_REPLICATE1_F21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_G07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29998.31 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_F20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_F17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.86 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_F19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_F18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.88 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_F16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.05 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_F11


title: 2D_RG_PLATE1_REPLICATE1_F15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.98 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_F14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_F13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.63 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_F10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9488.41 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_F12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.50 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_F09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.30 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_F08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30004.98 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_F06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94884.09 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_G03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299983.06 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_F03


title: 2D_RG_PLATE1_REPLICATE1_G04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300049.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE1_F02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_F04


title: 2D_RG_PLATE1_REPLICATE1_F07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29998.31 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_E23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_F01


title: 2D_RG_PLATE1_REPLICATE1_E24


title: 2D_RG_PLATE1_REPLICATE1_E22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_E21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.48 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_E20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.01 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_E19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29.99 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_E13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.43 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_E14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 949.05 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_E17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.84 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_E10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9490.50 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_F05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94862.97 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE1_E12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3001.16 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_E07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29991.95 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_E08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30011.60 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_E09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9484.29 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_E06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94905.00 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_E03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299919.48 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_E11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.19 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_E05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94842.87 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_D23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_E02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_E04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300115.97 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_D22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_E18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.91 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_D19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29.99 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_D18


title: 2D_RG_PLATE1_REPLICATE1_E01


title: 2D_RG_PLATE1_REPLICATE1_D15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.92 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_D17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.84 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_D16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.12 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_E16


title: 2D_RG_PLATE1_REPLICATE1_E15


title: 2D_RG_PLATE1_REPLICATE1_D24


title: 2D_RG_PLATE1_REPLICATE1_D21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.48 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_D10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9490.50 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_D13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.43 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_D12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3001.16 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_D05


title: 2D_RG_PLATE1_REPLICATE1_D04


title: 2D_RG_PLATE1_REPLICATE1_D08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30011.60 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_D09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9484.29 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_D11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.19 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_D20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.01 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_D07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29991.95 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_C22


title: 2D_RG_PLATE1_REPLICATE1_D14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 949.05 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_C23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE1_D02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_C19


title: 2D_RG_PLATE1_REPLICATE1_C20


title: 2D_RG_PLATE1_REPLICATE1_C24


title: 2D_RG_PLATE1_REPLICATE1_D03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299919.48 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_C16


title: 2D_RG_PLATE1_REPLICATE1_C18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.91 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_C17


title: 2D_RG_PLATE1_REPLICATE1_C14


title: 2D_RG_PLATE1_REPLICATE1_C12


title: 2D_RG_PLATE1_REPLICATE1_C15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.92 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_C10


title: 2D_RG_PLATE1_REPLICATE1_D06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94905.00 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_C09


title: 2D_RG_PLATE1_REPLICATE1_C13


title: 2D_RG_PLATE1_REPLICATE1_C11


title: 2D_RG_PLATE1_REPLICATE1_D01


title: 2D_RG_PLATE1_REPLICATE1_C08


title: 2D_RG_PLATE1_REPLICATE1_C07


title: 2D_RG_PLATE1_REPLICATE1_C21


title: 2D_RG_PLATE1_REPLICATE1_C04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300115.97 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE1_C02


title: 2D_RG_PLATE1_REPLICATE1_C03


title: 2D_RG_PLATE1_REPLICATE1_C06


title: 2D_RG_PLATE1_REPLICATE1_C01


title: 2D_RG_PLATE1_REPLICATE1_B20


title: 2D_RG_PLATE1_REPLICATE1_C05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94842.87 nM of KCl


title: 2D_RG_PLATE1_REPLICATE1_B16


title: 2D_RG_PLATE1_REPLICATE1_B22


title: 2D_RG_PLATE1_REPLICATE1_B14


title: 2D_RG_PLATE1_REPLICATE1_B15


title: 2D_RG_PLATE1_REPLICATE1_B13


title: 2D_RG_PLATE1_REPLICATE1_B21


title: 2D_RG_PLATE1_REPLICATE1_B18


title: 2D_RG_PLATE1_REPLICATE1_B17


title: 2D_RG_PLATE1_REPLICATE1_B06


title: 2D_RG_PLATE1_REPLICATE1_B19


title: 2D_RG_PLATE1_REPLICATE1_B12


title: 2D_RG_PLATE1_REPLICATE1_B05


title: 2D_RG_PLATE1_REPLICATE1_B09


title: 2D_RG_PLATE1_REPLICATE1_B08


title: 2D_RG_PLATE1_REPLICATE1_B11


title: 2D_RG_PLATE1_REPLICATE1_B10


title: 2D_RG_PLATE1_REPLICATE1_B07


title: 2D_RG_PLATE1_REPLICATE1_A18


title: 2D_RG_PLATE1_REPLICATE1_A16


title: 2D_RG_PLATE1_REPLICATE1_A14


title: 2D_RG_PLATE1_REPLICATE1_A11


title: 2D_RG_PLATE1_REPLICATE1_A12


title: 2D_RG_PLATE1_REPLICATE1_B04


title: 2D_RG_PLATE1_REPLICATE1_A22


title: 2D_RG_PLATE1_REPLICATE1_B03


title: 2D_RG_PLATE1_REPLICATE1_A05


title: 2D_RG_PLATE1_REPLICATE1_A21


title: 2D_RG_PLATE1_REPLICATE1_A20


title: 2D_PROL_PLATE4_REPLICATE3_P22

source_name: RNA-Seq of undifferentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE1_A19


title: 2D_PROL_PLATE4_REPLICATE3_P21


title: 2D_RG_PLATE1_REPLICATE1_A17


title: 2D_PROL_PLATE4_REPLICATE3_P16


title: 2D_RG_PLATE1_REPLICATE1_A15


title: 2D_PROL_PLATE4_REPLICATE3_P18


title: 2D_PROL_PLATE4_REPLICATE3_P17


title: 2D_PROL_PLATE4_REPLICATE3_P19


title: 2D_RG_PLATE1_REPLICATE1_A09


title: 2D_RG_PLATE1_REPLICATE1_A10


title: 2D_RG_PLATE1_REPLICATE1_A13


title: 2D_RG_PLATE1_REPLICATE1_A08


title: 2D_RG_PLATE1_REPLICATE1_A07


title: 2D_PROL_PLATE4_REPLICATE3_P12


title: 2D_RG_PLATE1_REPLICATE1_A03


title: 2D_RG_PLATE1_REPLICATE1_A04


title: 2D_RG_PLATE1_REPLICATE1_A06


title: 2D_PROL_PLATE4_REPLICATE3_P07


title: 2D_PROL_PLATE4_REPLICATE3_P20


title: 2D_PROL_PLATE4_REPLICATE3_P14


title: 2D_PROL_PLATE4_REPLICATE3_P13


title: 2D_PROL_PLATE4_REPLICATE3_O22


title: 2D_PROL_PLATE4_REPLICATE3_P10


title: 2D_PROL_PLATE4_REPLICATE3_P09


title: 2D_PROL_PLATE4_REPLICATE3_P08


title: 2D_PROL_PLATE4_REPLICATE3_P11


title: 2D_PROL_PLATE4_REPLICATE3_O20


title: 2D_PROL_PLATE4_REPLICATE3_P03


title: 2D_PROL_PLATE4_REPLICATE3_O13


title: 2D_PROL_PLATE4_REPLICATE3_P05


title: 2D_PROL_PLATE4_REPLICATE3_O21


title: 2D_PROL_PLATE4_REPLICATE3_O15


title: 2D_PROL_PLATE4_REPLICATE3_O18


title: 2D_PROL_PLATE4_REPLICATE3_P15


title: 2D_PROL_PLATE4_REPLICATE3_O14


title: 2D_PROL_PLATE4_REPLICATE3_O10


title: 2D_PROL_PLATE4_REPLICATE3_O12


title: 2D_PROL_PLATE4_REPLICATE3_P06


title: 2D_PROL_PLATE4_REPLICATE3_O11


title: 2D_PROL_PLATE4_REPLICATE3_O06


title: 2D_PROL_PLATE4_REPLICATE3_O08


title: 2D_PROL_PLATE4_REPLICATE3_O05


title: 2D_PROL_PLATE4_REPLICATE3_O07


title: 2D_PROL_PLATE4_REPLICATE3_O09


title: 2D_PROL_PLATE4_REPLICATE3_O04


title: 2D_PROL_PLATE4_REPLICATE3_P04


title: 2D_PROL_PLATE4_REPLICATE3_N24


title: 2D_PROL_PLATE4_REPLICATE3_O19


title: 2D_PROL_PLATE4_REPLICATE3_O17


title: 2D_PROL_PLATE4_REPLICATE3_O16


title: 2D_PROL_PLATE4_REPLICATE3_N23


title: 2D_PROL_PLATE4_REPLICATE3_N20


title: 2D_PROL_PLATE4_REPLICATE3_N21


title: 2D_PROL_PLATE4_REPLICATE3_N18


title: 2D_PROL_PLATE4_REPLICATE3_N13


title: 2D_PROL_PLATE4_REPLICATE3_N17


title: 2D_PROL_PLATE4_REPLICATE3_N12


title: 2D_PROL_PLATE4_REPLICATE3_N11


title: 2D_PROL_PLATE4_REPLICATE3_N14


title: 2D_PROL_PLATE4_REPLICATE3_N15


title: 2D_PROL_PLATE4_REPLICATE3_N10


title: 2D_PROL_PLATE4_REPLICATE3_O03


title: 2D_PROL_PLATE4_REPLICATE3_N05


title: 2D_PROL_PLATE4_REPLICATE3_N06


title: 2D_PROL_PLATE4_REPLICATE3_N03


title: 2D_PROL_PLATE4_REPLICATE3_N07


title: 2D_PROL_PLATE4_REPLICATE3_N04


title: 2D_PROL_PLATE4_REPLICATE3_N01


title: 2D_PROL_PLATE4_REPLICATE3_N08


title: 2D_PROL_PLATE4_REPLICATE3_N02


title: 2D_PROL_PLATE4_REPLICATE3_M23


title: 2D_PROL_PLATE4_REPLICATE3_M24


title: 2D_PROL_PLATE4_REPLICATE3_M22


title: 2D_PROL_PLATE4_REPLICATE3_M19


title: 2D_PROL_PLATE4_REPLICATE3_N22


title: 2D_PROL_PLATE4_REPLICATE3_M20


title: 2D_PROL_PLATE4_REPLICATE3_N19


title: 2D_PROL_PLATE4_REPLICATE3_M18


title: 2D_PROL_PLATE4_REPLICATE3_N16


title: 2D_PROL_PLATE4_REPLICATE3_N09


title: 2D_PROL_PLATE4_REPLICATE3_M17


title: 2D_PROL_PLATE4_REPLICATE3_M16


title: 2D_PROL_PLATE4_REPLICATE3_M10


title: 2D_PROL_PLATE4_REPLICATE3_M15


title: 2D_PROL_PLATE4_REPLICATE3_M14


title: 2D_PROL_PLATE4_REPLICATE3_M21


title: 2D_PROL_PLATE4_REPLICATE3_M09


title: 2D_PROL_PLATE4_REPLICATE3_M13


title: 2D_PROL_PLATE4_REPLICATE3_M11


title: 2D_PROL_PLATE4_REPLICATE3_M08


title: 2D_PROL_PLATE4_REPLICATE3_M04


title: 2D_PROL_PLATE4_REPLICATE3_L24


title: 2D_PROL_PLATE4_REPLICATE3_M07


title: 2D_PROL_PLATE4_REPLICATE3_M02


title: 2D_PROL_PLATE4_REPLICATE3_M06


title: 2D_PROL_PLATE4_REPLICATE3_M05


title: 2D_PROL_PLATE4_REPLICATE3_M03


title: 2D_PROL_PLATE4_REPLICATE3_M01


title: 2D_PROL_PLATE4_REPLICATE3_L22


title: 2D_PROL_PLATE4_REPLICATE3_L20


title: 2D_PROL_PLATE4_REPLICATE3_L21


title: 2D_PROL_PLATE4_REPLICATE3_L18


title: 2D_PROL_PLATE4_REPLICATE3_L19


title: 2D_PROL_PLATE4_REPLICATE3_M12


title: 2D_PROL_PLATE4_REPLICATE3_L16


title: 2D_PROL_PLATE4_REPLICATE3_L15


title: 2D_PROL_PLATE4_REPLICATE3_L14


title: 2D_PROL_PLATE4_REPLICATE3_L12


title: 2D_PROL_PLATE4_REPLICATE3_L23


title: 2D_PROL_PLATE4_REPLICATE3_L10


title: 2D_PROL_PLATE4_REPLICATE3_L06


title: 2D_PROL_PLATE4_REPLICATE3_L05


title: 2D_PROL_PLATE4_REPLICATE3_L04


title: 2D_PROL_PLATE4_REPLICATE3_L07


title: 2D_PROL_PLATE4_REPLICATE3_L03


title: 2D_PROL_PLATE4_REPLICATE3_L13


title: 2D_PROL_PLATE4_REPLICATE3_L01


title: 2D_PROL_PLATE4_REPLICATE3_K24


title: 2D_PROL_PLATE4_REPLICATE3_K23


title: 2D_PROL_PLATE4_REPLICATE3_L02


title: 2D_PROL_PLATE4_REPLICATE3_L17


title: 2D_PROL_PLATE4_REPLICATE3_K20


title: 2D_PROL_PLATE4_REPLICATE3_K22


title: 2D_RG_PLATE2_REPLICATE1_G05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94878.41 nM of DMN

value: DMN


title: 2D_RG_PLATE2_REPLICATE1_G04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300040.18 nM of sucrose

value: sucrose


title: 2D_RG_PLATE2_REPLICATE1_G02

value: HepaRG cells


title: 2D_RG_PLATE2_REPLICATE1_G07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30003.19 nM of DMN

value: unpurified cell lysates


title: 2D_RG_PLATE2_REPLICATE1_G01


title: 2D_RG_PLATE2_REPLICATE1_F23

value: 96 hours


title: 2D_RG_PLATE2_REPLICATE1_F24


title: 2D_RG_PLATE2_REPLICATE1_F19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of DMN

value: 30 nM


title: 2D_RG_PLATE2_REPLICATE1_F22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.04 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of DMN


title: 2D_RG_PLATE2_REPLICATE1_F17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.88 nM of DMN


title: 2D_PROL_PLATE4_REPLICATE3_K21


title: 2D_RG_PLATE2_REPLICATE1_F14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.81 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.78 nM of DMN


title: 2D_RG_PLATE2_REPLICATE1_F12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.40 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9488.10 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.03 nM of DMN


title: 2D_RG_PLATE2_REPLICATE1_F09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9487.84 nM of DMN


title: 2D_RG_PLATE2_REPLICATE1_F07


title: 2D_RG_PLATE2_REPLICATE1_F08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30004.02 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94881.04 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.88 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_F05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94878.41 nM of DMN


title: 2D_RG_PLATE2_REPLICATE1_E24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE2_REPLICATE1_F01

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE2_REPLICATE1_G03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300031.89 nM of DMN


title: 2D_RG_PLATE2_REPLICATE1_F11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.32 nM of DMN


title: 2D_RG_PLATE2_REPLICATE1_F03


title: 2D_RG_PLATE2_REPLICATE1_F02


title: 2D_RG_PLATE2_REPLICATE1_E23


title: 2D_RG_PLATE2_REPLICATE1_E21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2.96 nM of tamoxifen

value: tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_E20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29.82 nM of ritonavir

value: ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.36 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_E18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.29 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 298.16 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 935.72 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_E15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 93.57 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_E10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9428.70 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 942.87 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2981.62 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29.59 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_F04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300040.18 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_E09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2959.01 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_E06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94286.96 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.43 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 295.90 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_E08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29816.15 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29590.10 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_E04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 298161.55 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE2_REPLICATE1_D24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO

value: DMSO


title: 2D_RG_PLATE2_REPLICATE1_D23


title: 2D_RG_PLATE2_REPLICATE1_E03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 93572.12 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_D22


title: 2D_RG_PLATE2_REPLICATE1_D20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29.82 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9357.21 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_D16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 298.16 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_D17


title: 2D_RG_PLATE2_REPLICATE1_D15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 93.57 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_D12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2981.62 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_E01


title: 2D_RG_PLATE2_REPLICATE1_D18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.29 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_D13


title: 2D_RG_PLATE2_REPLICATE1_D10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9428.70 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_D07


title: 2D_RG_PLATE2_REPLICATE1_D09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2959.01 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_D06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94286.96 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_D08


title: 2D_RG_PLATE2_REPLICATE1_D21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2.96 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_D03


title: 2D_RG_PLATE2_REPLICATE1_D19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.36 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_D01


title: 2D_RG_PLATE2_REPLICATE1_C24


title: 2D_RG_PLATE2_REPLICATE1_D14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 942.87 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_C23


title: 2D_PROL_PLATE4_REPLICATE3_L11

source_name: RNA-Seq of undifferentiated HepaRG cells in culture


title: 2D_RG_PLATE2_REPLICATE1_C22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.43 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_C21


title: 2D_RG_PLATE2_REPLICATE1_C19


title: 2D_RG_PLATE2_REPLICATE1_C20


title: 2D_RG_PLATE2_REPLICATE1_C18


title: 2D_RG_PLATE2_REPLICATE1_C17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29.59 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_C14


title: 2D_RG_PLATE2_REPLICATE1_C15


title: 2D_RG_PLATE2_REPLICATE1_C12


title: 2D_RG_PLATE2_REPLICATE1_C13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 295.90 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_C16


title: 2D_RG_PLATE2_REPLICATE1_D04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 298161.55 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_C11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 935.72 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_C10


title: 2D_RG_PLATE2_REPLICATE1_D02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE2_REPLICATE1_C09


title: 2D_RG_PLATE2_REPLICATE1_G06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94881.04 nM of sucrose


title: 2D_RG_PLATE2_REPLICATE1_C06


title: 2D_RG_PLATE2_REPLICATE1_C05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29590.10 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_C04


title: 2D_RG_PLATE2_REPLICATE1_D11


title: 2D_RG_PLATE2_REPLICATE1_B21


title: 2D_RG_PLATE2_REPLICATE1_B22


title: 2D_RG_PLATE2_REPLICATE1_C02


title: 2D_RG_PLATE2_REPLICATE1_B20


title: 2D_RG_PLATE2_REPLICATE1_B17


title: 2D_RG_PLATE2_REPLICATE1_B19


title: 2D_RG_PLATE2_REPLICATE1_B15


title: 2D_RG_PLATE2_REPLICATE1_B16


title: 2D_RG_PLATE2_REPLICATE1_B14


title: 2D_RG_PLATE2_REPLICATE1_B13


title: 2D_RG_PLATE2_REPLICATE1_B12


title: 2D_RG_PLATE2_REPLICATE1_C03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 93572.12 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_B10


title: 2D_RG_PLATE2_REPLICATE1_B07


title: 2D_RG_PLATE2_REPLICATE1_B05


title: 2D_RG_PLATE2_REPLICATE1_B09


title: 2D_RG_PLATE2_REPLICATE1_C01


title: 2D_RG_PLATE2_REPLICATE1_C07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9357.21 nM of tamoxifen


title: 2D_RG_PLATE2_REPLICATE1_A21


title: 2D_RG_PLATE2_REPLICATE1_B03


title: 2D_RG_PLATE2_REPLICATE1_A18


title: 2D_RG_PLATE2_REPLICATE1_A20


title: 2D_RG_PLATE2_REPLICATE1_A19


title: 2D_PROL_PLATE4_REPLICATE3_L09


title: 2D_RG_PLATE2_REPLICATE1_A17


title: 2D_RG_PLATE2_REPLICATE1_B18


title: 2D_RG_PLATE2_REPLICATE1_B08


title: 2D_RG_PLATE2_REPLICATE1_C08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29816.15 nM of ritonavir


title: 2D_RG_PLATE2_REPLICATE1_B11


title: 2D_RG_PLATE2_REPLICATE1_A15


title: 2D_RG_PLATE2_REPLICATE1_A16


title: 2D_RG_PLATE2_REPLICATE1_B06


title: 2D_RG_PLATE2_REPLICATE1_A12


title: 2D_RG_PLATE2_REPLICATE1_B04


title: 2D_RG_PLATE2_REPLICATE1_A13


title: 2D_RG_PLATE2_REPLICATE1_A05


title: 2D_RG_PLATE2_REPLICATE1_A07


title: 2D_RG_PLATE2_REPLICATE1_A10


title: 2D_RG_PLATE2_REPLICATE1_A06


title: 2D_RG_PLATE2_REPLICATE1_A11


title: 2D_RG_PLATE2_REPLICATE1_A08


title: 2D_RG_PLATE2_REPLICATE1_A04


title: 2D_RG_PLATE1_REPLICATE3_P21


title: 2D_RG_PLATE1_REPLICATE3_P22


title: 2D_RG_PLATE2_REPLICATE1_A03


title: 2D_RG_PLATE1_REPLICATE3_P20


title: 2D_RG_PLATE1_REPLICATE3_P18


title: 2D_RG_PLATE1_REPLICATE3_P19


title: 2D_RG_PLATE2_REPLICATE1_A14


title: 2D_RG_PLATE1_REPLICATE3_P16


title: 2D_RG_PLATE1_REPLICATE3_P17


title: 2D_RG_PLATE1_REPLICATE3_P15


title: 2D_RG_PLATE2_REPLICATE1_A09


title: 2D_RG_PLATE1_REPLICATE3_P14


title: 2D_RG_PLATE1_REPLICATE3_P13


title: 2D_RG_PLATE1_REPLICATE3_P11


title: 2D_RG_PLATE1_REPLICATE3_P12


title: 2D_RG_PLATE1_REPLICATE3_P10


title: 2D_RG_PLATE1_REPLICATE3_P08


title: 2D_RG_PLATE1_REPLICATE3_P07


title: 2D_RG_PLATE2_REPLICATE1_A22


title: 2D_RG_PLATE1_REPLICATE3_P09


title: 2D_RG_PLATE2_REPLICATE1_D05


title: 2D_RG_PLATE1_REPLICATE3_P04


title: 2D_RG_PLATE1_REPLICATE3_P05


title: 2D_RG_PLATE1_REPLICATE3_O20


title: 2D_RG_PLATE1_REPLICATE3_P03


title: 2D_RG_PLATE1_REPLICATE3_O21


title: 2D_RG_PLATE1_REPLICATE3_O22


title: 2D_RG_PLATE1_REPLICATE3_O19


title: 2D_RG_PLATE1_REPLICATE3_O17


title: 2D_RG_PLATE1_REPLICATE3_O16


title: 2D_RG_PLATE1_REPLICATE3_O15


title: 2D_RG_PLATE1_REPLICATE3_O13


title: 2D_RG_PLATE1_REPLICATE3_O11


title: 2D_RG_PLATE1_REPLICATE3_O14


title: 2D_RG_PLATE1_REPLICATE3_O09


title: 2D_RG_PLATE1_REPLICATE3_O18


title: 2D_RG_PLATE1_REPLICATE3_O07


title: 2D_RG_PLATE1_REPLICATE3_P06


title: 2D_RG_PLATE1_REPLICATE3_O08


title: 2D_RG_PLATE1_REPLICATE3_O05


title: 2D_RG_PLATE1_REPLICATE3_N23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE3_O03


title: 2D_RG_PLATE1_REPLICATE3_O06


title: 2D_RG_PLATE1_REPLICATE3_N21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4.74 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_N24


title: 2D_RG_PLATE1_REPLICATE3_O12


title: 2D_RG_PLATE1_REPLICATE3_N20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_O04


title: 2D_RG_PLATE1_REPLICATE3_N22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 0.95 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_N15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149.97 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_N16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_N18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_N19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 15.00 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_N14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.87 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_N13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 474.25 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_N11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 1499.72 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_O10

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE3_N09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4742.54 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_N12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_N10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.67 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_N08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.95 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_N03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149972.33 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_M24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE3_N06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.69 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_N02


title: 2D_RG_PLATE1_REPLICATE3_M22


title: 2D_RG_PLATE1_REPLICATE3_M23


title: 2D_RG_PLATE1_REPLICATE3_N05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 47425.41 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_M21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4.74 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_M19


title: 2D_RG_PLATE1_REPLICATE3_M20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_M15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149.97 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_M16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_M14


title: 2D_RG_PLATE1_REPLICATE3_M17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 47.43 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_M18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_M13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 474.25 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_M12


title: 2D_RG_PLATE1_REPLICATE3_N17


title: 2D_RG_PLATE1_REPLICATE3_M10


title: 2D_RG_PLATE1_REPLICATE3_M11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 1499.72 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_M09


title: 2D_RG_PLATE1_REPLICATE3_N04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29999.55 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_M08


title: 2D_RG_PLATE1_REPLICATE3_M06


title: 2D_RG_PLATE1_REPLICATE3_N01

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE3_N07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 14997.23 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_M05


title: 2D_RG_PLATE1_REPLICATE3_M04


title: 2D_RG_PLATE1_REPLICATE3_M03


title: 2D_RG_PLATE1_REPLICATE3_M02


title: 2D_RG_PLATE1_REPLICATE3_L24


title: 2D_RG_PLATE1_REPLICATE3_M01


title: 2D_RG_PLATE1_REPLICATE3_L21


title: 2D_RG_PLATE1_REPLICATE3_L23


title: 2D_RG_PLATE1_REPLICATE3_L22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 0.95 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_L20


title: 2D_RG_PLATE1_REPLICATE3_L19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 15.00 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_L17


title: 2D_RG_PLATE1_REPLICATE3_L14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.87 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_L12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_L13


title: 2D_RG_PLATE1_REPLICATE3_L11


title: 2D_RG_PLATE1_REPLICATE3_L10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.67 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_M07


title: 2D_RG_PLATE1_REPLICATE3_L08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.95 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_L09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 4742.54 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_L06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.69 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_L04


title: 2D_PROL_PLATE4_REPLICATE3_L08

source_name: RNA-Seq of undifferentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE3_L03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149972.33 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_L18


title: 2D_RG_PLATE1_REPLICATE3_L07


title: 2D_RG_PLATE1_REPLICATE3_L05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 47425.41 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_K16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.01 nM of aspirin

value: aspirin


title: 2D_RG_PLATE1_REPLICATE3_L15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 149.97 nM of aflatoxin B1


title: 2D_RG_PLATE1_REPLICATE3_K20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_L02


title: 2D_RG_PLATE1_REPLICATE3_K18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.87 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_K21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 6.33 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_L01

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE3_K15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 200.04 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_L16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of B[a]P


title: 2D_RG_PLATE1_REPLICATE3_K13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 632.57 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_K22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_K12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.12 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_K19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 20.00 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_K09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 6325.73 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_K23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE3_K17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63.26 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_K11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2000.37 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_K03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 200037.13 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_K02


title: 2D_RG_PLATE1_REPLICATE3_K01


title: 2D_RG_PLATE1_REPLICATE3_J23


title: 2D_RG_PLATE1_REPLICATE3_J18


title: 2D_RG_PLATE1_REPLICATE3_K07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 20003.71 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_J19


title: 2D_RG_PLATE1_REPLICATE3_J17


title: 2D_RG_PLATE1_REPLICATE3_K05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63257.30 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_K04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300011.51 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_J14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.72 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_J13


title: 2D_RG_PLATE1_REPLICATE3_J10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9487.20 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_K24


title: 2D_RG_PLATE1_REPLICATE3_J08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30001.15 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_J21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 6.33 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_J16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.01 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_J22


title: 2D_RG_PLATE1_REPLICATE3_J15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 200.04 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_J03


title: 2D_RG_PLATE1_REPLICATE3_K14


title: 2D_RG_PLATE1_REPLICATE3_K08


title: 2D_RG_PLATE1_REPLICATE3_J20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_K10


title: 2D_RG_PLATE1_REPLICATE3_I23


title: 2D_RG_PLATE1_REPLICATE3_I21


title: 2D_RG_PLATE1_REPLICATE3_K06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94871.97 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_J07


title: 2D_RG_PLATE1_REPLICATE3_J11


title: 2D_RG_PLATE1_REPLICATE3_J12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.12 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_I15


title: 2D_RG_PLATE1_REPLICATE3_J09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 6325.73 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_J06


title: 2D_RG_PLATE1_REPLICATE3_J24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE3_I13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 632.57 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_I14


title: 2D_RG_PLATE1_REPLICATE3_J05


title: 2D_RG_PLATE1_REPLICATE3_I11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2000.37 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_I09


title: 2D_RG_PLATE1_REPLICATE3_J02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE3_I08


title: 2D_RG_PLATE1_REPLICATE3_J01


title: 2D_RG_PLATE1_REPLICATE3_I07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 20003.71 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_I10


title: 2D_RG_PLATE1_REPLICATE3_I06


title: 2D_RG_PLATE1_REPLICATE3_I04


title: 2D_RG_PLATE1_REPLICATE3_I05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63257.30 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_I17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 63.26 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_I18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.87 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_I16


title: 2D_RG_PLATE1_REPLICATE3_I20


title: 2D_RG_PLATE1_REPLICATE3_H23


title: 2D_RG_PLATE1_REPLICATE3_I22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_I12


title: 2D_RG_PLATE1_REPLICATE3_J04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300011.51 nM of aspirin


title: 2D_RG_PLATE1_REPLICATE3_H20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of rosiglitazone

value: rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_H24


title: 2D_RG_PLATE1_REPLICATE3_I19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 20.00 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_I03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 200037.13 nM of CDCA


title: 2D_RG_PLATE1_REPLICATE3_H17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.86 nM of cyclophosphamide

value: cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.05 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_I02


title: 2D_RG_PLATE1_REPLICATE3_H09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.30 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30004.98 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_H06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94884.09 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_I01


title: 2D_RG_PLATE1_REPLICATE3_H07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29998.31 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94862.97 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_I24

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE3_H03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299983.06 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_H04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300049.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_H02

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE3_H15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.98 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H01


title: 2D_RG_PLATE1_REPLICATE3_H12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.50 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_G23


title: 2D_RG_PLATE1_REPLICATE3_G21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H13

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.63 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.83 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_H10

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9488.41 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_G17

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.86 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_G16

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300.05 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_G15


title: 2D_RG_PLATE1_REPLICATE3_G11


title: 2D_RG_PLATE1_REPLICATE3_G22


title: 2D_RG_PLATE1_REPLICATE3_G10


title: 2D_RG_PLATE1_REPLICATE3_H14

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 948.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_G07


title: 2D_RG_PLATE1_REPLICATE3_G02


title: 2D_RG_PLATE1_REPLICATE3_H18

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94.88 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_G01


title: 2D_RG_PLATE1_REPLICATE3_G19

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_F24


title: 2D_RG_PLATE1_REPLICATE3_G12


title: 2D_RG_PLATE1_REPLICATE3_G24


title: 2D_RG_PLATE1_REPLICATE3_G06

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94884.09 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_G04


title: 2D_RG_PLATE1_REPLICATE3_G20

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30.00 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_G13


title: 2D_RG_PLATE1_REPLICATE3_G08

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 30004.98 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_G09

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9486.30 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_F16


title: 2D_RG_PLATE1_REPLICATE3_G05

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 94862.97 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_G18


title: 2D_RG_PLATE1_REPLICATE3_H21


title: 2D_RG_PLATE1_REPLICATE3_F21


title: 2D_RG_PLATE1_REPLICATE3_F13


title: 2D_RG_PLATE1_REPLICATE3_F11


title: 2D_RG_PLATE1_REPLICATE3_G03

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299983.06 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_F10


title: 2D_RG_PLATE1_REPLICATE3_G14


title: 2D_RG_PLATE1_REPLICATE3_F23

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to DMSO


title: 2D_RG_PLATE1_REPLICATE3_F06


title: 2D_RG_PLATE1_REPLICATE3_F19


title: 2D_RG_PLATE1_REPLICATE3_F17


title: 2D_RG_PLATE1_REPLICATE3_F22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_F20


title: 2D_RG_PLATE1_REPLICATE3_F08


title: 2D_RG_PLATE1_REPLICATE3_F01

source_name: RNA-Seq of differentiated HepaRG cells in culture


title: 2D_RG_PLATE1_REPLICATE3_E22

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.49 nM of troglitazone

value: troglitazone


title: 2D_RG_PLATE1_REPLICATE3_E24


title: 2D_RG_PLATE1_REPLICATE3_E21

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 9.48 nM of KCl

value: KCl


title: 2D_RG_PLATE1_REPLICATE3_F09


title: 2D_RG_PLATE1_REPLICATE3_F15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.98 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_F04

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 300049.84 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_F18


title: 2D_RG_PLATE1_REPLICATE3_E15

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 299.92 nM of KCl


title: 2D_RG_PLATE1_REPLICATE3_E23


title: 2D_RG_PLATE1_REPLICATE3_F07

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 29998.31 nM of cyclophosphamide


title: 2D_RG_PLATE1_REPLICATE3_F03


title: 2D_RG_PLATE1_REPLICATE3_F12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3000.50 nM of rosiglitazone


title: 2D_RG_PLATE1_REPLICATE3_E12

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 3001.16 nM of troglitazone


title: 2D_RG_PLATE1_REPLICATE3_E11

source_name: RNA-Seq of differentiated HepaRG cells in culture, after 96 hours of exposure to 2999.19 nM of KCl